Title: Full Text of SB1553
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of SB1553 ILGA.GOV SB1553 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB1553 Introduced 2/4/2025, by Sen. Patrick J. Joyce SYNOPSIS AS INTRODUCED: 720 ILCS 570/208  from Ch. 56 1/2, par. 1208720 ILCS 570/309.1 new720 ILCS 570/401  from Ch. 56 1/2, par. 1401    Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.LRB104 10684 RTM 20763 b  A BILL FOR SB1553LRB104 10684 RTM 20763 b1    AN ACT concerning criminal law. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Controlled Substances Act is 5amended by changing Sections 208 and 401 and by adding Section 6309.1 as follows: 7    (720 ILCS 570/208)  (from Ch. 56 1/2, par. 1208)8    Sec. 208. (a) The controlled substances listed in this 9Section are included in Schedule III.10    (b) Unless specifically excepted or unless listed in 11another schedule, any material, compound, mixture, or 12preparation which contains any quantity of the following 13substances having a stimulant effect on the central nervous 14system, including its salts, isomers (whether optical 15position, or geometric), and salts of such isomers whenever 16the existence of such salts, isomers, and salts of isomers is 17possible within the specific chemical designation;18        (1) Those compounds, mixtures, or preparations in 19    dosage unit form containing any stimulant substances 20    listed in Schedule II which compounds, mixtures, or 21    preparations were listed on August 25, 1971, as excepted 22    compounds under Title 21, Code of Federal Regulations, 23    Section 308.32, and any other drug of the quantitative   SB1553- 2 -LRB104 10684 RTM 20763 b1    composition shown in that list for those drugs or which is 2    the same except that it contains a lesser quantity of 3    controlled substances;4        (2) Benzphetamine;5        (3) Chlorphentermine;6        (4) Clortermine;7        (5) Phendimetrazine.8    (c) Unless specifically excepted or unless listed in 9another schedule, any material, compound, mixture, or 10preparation which contains any quantity of the following 11substances having a potential for misuse associated with a 12depressant effect on the central nervous system:13        (1) Any compound, mixture, or preparation containing 14    amobarbital, secobarbital, pentobarbital or any salt 15    thereof and one or more other active medicinal ingredients 16    which are not listed in any schedule;17        (2) Any suppository dosage form containing 18    amobarbital, secobarbital, pentobarbital or any salt of 19    any of these drugs and approved by the Federal Food and 20    Drug Administration for marketing only as a suppository;21        (3) Any substance which contains any quantity of a 22    derivative of barbituric acid, or any salt thereof:23        (3.1) Aprobarbital;24        (3.2) Butabarbital (secbutabarbital);25        (3.3) Butalbital;26        (3.4) Butobarbital (butethal);   SB1553- 3 -LRB104 10684 RTM 20763 b1        (4) Chlorhexadol;2        (5) Methyprylon;3        (6) Sulfondiethylmethane;4        (7) Sulfonethylmethane;5        (8) Sulfonmethane;6        (9) Lysergic acid;7        (10) Lysergic acid amide;8        (10.1) Tiletamine or zolazepam or both, or any salt of 9    either of them.10    Some trade or other names for a tiletamine-zolazepam 11    combination product: Telazol. 12    Some trade or other names for Tiletamine: 13    2-(ethylamino)-2-(2-thienyl)-cyclohexanone. 14    Some trade or other names for zolazepam: 15    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo- 16    [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.17        (11) Any material, compound, mixture or preparation 18    containing not more than 12.5 milligrams of pentazocine or 19    any of its salts, per 325 milligrams of aspirin;20        (12) Any material, compound, mixture or preparation 21    containing not more than 12.5 milligrams of pentazocine or 22    any of its salts, per 325 milligrams of acetaminophen;23        (13) Any material, compound, mixture or preparation 24    containing not more than 50 milligrams of pentazocine or 25    any of its salts plus naloxone HCl USP 0.5 milligrams, per 26    dosage unit;  SB1553- 4 -LRB104 10684 RTM 20763 b1        (14) Ketamine;2        (15) Thiopental; . 3        (16) xylazine. 4    (d) Nalorphine.5    (d.5) Buprenorphine. 6    (e) Unless specifically excepted or unless listed in 7another schedule, any material, compound, mixture, or 8preparation containing limited quantities of any of the 9following narcotic drugs, or their salts calculated as the 10free anhydrous base or alkaloid, as set forth below:11        (1) not more than 1.8 grams of codeine per 100 12    milliliters or not more than 90 milligrams per dosage 13    unit, with an equal or greater quantity of an isoquinoline 14    alkaloid of opium;15        (2) not more than 1.8 grams of codeine per 100 16    milliliters or not more than 90 milligrams per dosage 17    unit, with one or more active non-narcotic ingredients in 18    recognized therapeutic amounts;19        (3) (blank);20        (4) (blank);21        (5) not more than 1.8 grams of dihydrocodeine per 100 22    milliliters or not more than 90 milligrams per dosage 23    unit, with one or more active, non-narcotic ingredients in 24    recognized therapeutic amounts;25        (6) not more than 300 milligrams of ethylmorphine per 26    100 milliliters or not more than 15 milligrams per dosage   SB1553- 5 -LRB104 10684 RTM 20763 b1    unit, with one or more active, non-narcotic ingredients in 2    recognized therapeutic amounts;3        (7) not more than 500 milligrams of opium per 100 4    milliliters or per 100 grams, or not more than 25 5    milligrams per dosage unit, with one or more active, 6    non-narcotic ingredients in recognized therapeutic 7    amounts;8        (8) not more than 50 milligrams of morphine per 100 9    milliliters or per 100 grams with one or more active, 10    non-narcotic ingredients in recognized therapeutic 11    amounts.12    (f) Anabolic steroids, except the following anabolic 13steroids that are exempt:14        (1) Androgyn L.A.;15        (2) Andro-Estro 90-4;16        (3) depANDROGYN;17        (4) DEPO-T.E.;18        (5) depTESTROGEN;19        (6) Duomone;20        (7) DURATESTRIN;21        (8) DUO-SPAN II;22        (9) Estratest;23        (10) Estratest H.S.;24        (11) PAN ESTRA TEST;25        (12) Premarin with Methyltestosterone;26        (13) TEST-ESTRO Cypionates;  SB1553- 6 -LRB104 10684 RTM 20763 b1        (14) Testosterone Cyp 50 Estradiol Cyp 2;2        (15) Testosterone Cypionate-Estradiol Cypionate 3    injection; and4        (16) Testosterone Enanthate-Estradiol Valerate 5    injection.6    (g) Hallucinogenic substances.7        (1) Dronabinol (synthetic) in sesame oil and 8    encapsulated in a soft gelatin capsule in a U.S. Food and 9    Drug Administration approved product. Some other names for 10    dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro- 11    6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or 12    (-)-delta-9-(trans)-tetrahydrocannabinol.13        (2) (Reserved).14    (h) The Department may except by rule any compound, 15mixture, or preparation containing any stimulant or depressant 16substance listed in subsection (b) from the application of all 17or any part of this Act if the compound, mixture, or 18preparation contains one or more active medicinal ingredients 19not having a stimulant or depressant effect on the central 20nervous system, and if the admixtures are included therein in 21combinations, quantity, proportion, or concentration that 22vitiate the potential for misuse of the substances which have 23a stimulant or depressant effect on the central nervous 24system.25(Source: P.A. 103-881, eff. 1-1-25.)   SB1553- 7 -LRB104 10684 RTM 20763 b1    (720 ILCS 570/309.1 new)2    Sec. 309.1. Veterinarian; xylazine. Notwithstanding the 3scheduling of xylazine as a Schedule III controlled substance, 4the prohibition on delivery or possession with intent to 5deliver xylazine does not apply to licensed veterinarians who 6lawfully prescribe, dispense, administer, acquire, or use any 7controlled substance, including xylazine, while acting in the 8course of their professional practice, in good faith, and in 9accordance with generally accepted medical standards. 10    (720 ILCS 570/401)  (from Ch. 56 1/2, par. 1401)11    Sec. 401. Manufacture or delivery, or possession with 12intent to manufacture or deliver, a controlled substance, a 13counterfeit substance, or controlled substance analog. Except 14as authorized by this Act, it is unlawful for any person 15knowingly to manufacture or deliver, or possess with intent to 16manufacture or deliver, a controlled substance other than 17methamphetamine and other than bath salts as defined in the 18Bath Salts Prohibition Act sold or offered for sale in a retail 19mercantile establishment as defined in Section 16-0.1 of the 20Criminal Code of 2012, a counterfeit substance, or a 21controlled substance analog. A violation of this Act with 22respect to each of the controlled substances listed herein 23constitutes a single and separate violation of this Act. For 24purposes of this Section, "controlled substance analog" or 25"analog" means a substance, other than a controlled substance,   SB1553- 8 -LRB104 10684 RTM 20763 b1which is not approved by the United States Food and Drug 2Administration or, if approved, is not dispensed or possessed 3in accordance with State or federal law, and that has a 4chemical structure substantially similar to that of a 5controlled substance in Schedule I or II, or that was 6specifically designed to produce an effect substantially 7similar to that of a controlled substance in Schedule I or II. 8Examples of chemical classes in which controlled substance 9analogs are found include, but are not limited to, the 10following: phenethylamines, N-substituted piperidines, 11morphinans, ecgonines, quinazolinones, substituted indoles, 12and arylcycloalkylamines. For purposes of this Act, a 13controlled substance analog shall be treated in the same 14manner as the controlled substance to which it is 15substantially similar.16    (a) Any person who violates this Section with respect to 17the following amounts of controlled or counterfeit substances 18or controlled substance analogs, notwithstanding any of the 19provisions of subsections (c), (d), (e), (f), (g) or (h) to the 20contrary, is guilty of a Class X felony and shall be sentenced 21to a term of imprisonment as provided in this subsection (a) 22and fined as provided in subsection (b):23        (1)(A) not less than 6 years and not more than 30 years 24    with respect to 15 grams or more but less than 100 grams of 25    a substance containing heroin, or an analog thereof;26        (B) not less than 9 years and not more than 40 years   SB1553- 9 -LRB104 10684 RTM 20763 b1    with respect to 100 grams or more but less than 400 grams 2    of a substance containing heroin, or an analog thereof;3        (C) not less than 12 years and not more than 50 years 4    with respect to 400 grams or more but less than 900 grams 5    of a substance containing heroin, or an analog thereof;6        (D) not less than 15 years and not more than 60 years 7    with respect to 900 grams or more of any substance 8    containing heroin, or an analog thereof;9        (1.5)(A) not less than 6 years and not more than 30 10    years with respect to 15 grams or more but less than 100 11    grams of a substance containing fentanyl or xylazine, or 12    an analog thereof;13        (B) not less than 9 years and not more than 40 years 14    with respect to 100 grams or more but less than 400 grams 15    of a substance containing fentanyl or xylazine, or an 16    analog thereof;17        (C) not less than 12 years and not more than 50 years 18    with respect to 400 grams or more but less than 900 grams 19    of a substance containing fentanyl or xylazine, or an 20    analog thereof;21        (D) not less than 15 years and not more than 60 years 22    with respect to 900 grams or more of a substance 23    containing fentanyl or xylazine, or an analog thereof;24        (2)(A) not less than 6 years and not more than 30 years 25    with respect to 15 grams or more but less than 100 grams of 26    a substance containing cocaine, or an analog thereof;  SB1553- 10 -LRB104 10684 RTM 20763 b1        (B) not less than 9 years and not more than 40 years 2    with respect to 100 grams or more but less than 400 grams 3    of a substance containing cocaine, or an analog thereof;4        (C) not less than 12 years and not more than 50 years 5    with respect to 400 grams or more but less than 900 grams 6    of a substance containing cocaine, or an analog thereof;7        (D) not less than 15 years and not more than 60 years 8    with respect to 900 grams or more of any substance 9    containing cocaine, or an analog thereof;10        (3)(A) not less than 6 years and not more than 30 years 11    with respect to 15 grams or more but less than 100 grams of 12    a substance containing morphine, or an analog thereof;13        (B) not less than 9 years and not more than 40 years 14    with respect to 100 grams or more but less than 400 grams 15    of a substance containing morphine, or an analog thereof;16        (C) not less than 12 years and not more than 50 years 17    with respect to 400 grams or more but less than 900 grams 18    of a substance containing morphine, or an analog thereof;19        (D) not less than 15 years and not more than 60 years 20    with respect to 900 grams or more of a substance 21    containing morphine, or an analog thereof;22        (4) 200 grams or more of any substance containing 23    peyote, or an analog thereof;24        (5) 200 grams or more of any substance containing a 25    derivative of barbituric acid or any of the salts of a 26    derivative of barbituric acid, or an analog thereof;  SB1553- 11 -LRB104 10684 RTM 20763 b1        (6) 200 grams or more of any substance containing 2    amphetamine or any salt of an optical isomer of 3    amphetamine, or an analog thereof;4        (6.5) (blank);5        (6.6) (blank);6        (7)(A) not less than 6 years and not more than 30 years 7    with respect to: (i) 15 grams or more but less than 100 8    grams of a substance containing lysergic acid diethylamide 9    (LSD), or an analog thereof, or (ii) 15 or more objects or 10    15 or more segregated parts of an object or objects but 11    less than 200 objects or 200 segregated parts of an object 12    or objects containing in them or having upon them any 13    amounts of any substance containing lysergic acid 14    diethylamide (LSD), or an analog thereof;15        (B) not less than 9 years and not more than 40 years 16    with respect to: (i) 100 grams or more but less than 400 17    grams of a substance containing lysergic acid diethylamide 18    (LSD), or an analog thereof, or (ii) 200 or more objects or 19    200 or more segregated parts of an object or objects but 20    less than 600 objects or less than 600 segregated parts of 21    an object or objects containing in them or having upon 22    them any amount of any substance containing lysergic acid 23    diethylamide (LSD), or an analog thereof;24        (C) not less than 12 years and not more than 50 years 25    with respect to: (i) 400 grams or more but less than 900 26    grams of a substance containing lysergic acid diethylamide   SB1553- 12 -LRB104 10684 RTM 20763 b1    (LSD), or an analog thereof, or (ii) 600 or more objects or 2    600 or more segregated parts of an object or objects but 3    less than 1500 objects or 1500 segregated parts of an 4    object or objects containing in them or having upon them 5    any amount of any substance containing lysergic acid 6    diethylamide (LSD), or an analog thereof;7        (D) not less than 15 years and not more than 60 years 8    with respect to: (i) 900 grams or more of any substance 9    containing lysergic acid diethylamide (LSD), or an analog 10    thereof, or (ii) 1500 or more objects or 1500 or more 11    segregated parts of an object or objects containing in 12    them or having upon them any amount of a substance 13    containing lysergic acid diethylamide (LSD), or an analog 14    thereof;15    (7.5)(A) not less than 6 years and not more than 30 years 16    with respect to: (i) 15 grams or more but less than 100 17    grams of a substance listed in paragraph (1), (2), (2.1), 18    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or 19    (26) of subsection (d) of Section 204, or an analog or 20    derivative thereof, or (ii) 15 or more pills, tablets, 21    caplets, capsules, or objects but less than 200 pills, 22    tablets, caplets, capsules, or objects containing in them 23    or having upon them any amounts of any substance listed in 24    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), 25    (20.1), (21), (25), or (26) of subsection (d) of Section 26    204, or an analog or derivative thereof;  SB1553- 13 -LRB104 10684 RTM 20763 b1        (B) not less than 9 years and not more than 40 years 2    with respect to: (i) 100 grams or more but less than 400 3    grams of a substance listed in paragraph (1), (2), (2.1), 4    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or 5    (26) of subsection (d) of Section 204, or an analog or 6    derivative thereof, or (ii) 200 or more pills, tablets, 7    caplets, capsules, or objects but less than 600 pills, 8    tablets, caplets, capsules, or objects containing in them 9    or having upon them any amount of any substance listed in 10    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), 11    (20.1), (21), (25), or (26) of subsection (d) of Section 12    204, or an analog or derivative thereof;13        (C) not less than 12 years and not more than 50 years 14    with respect to: (i) 400 grams or more but less than 900 15    grams of a substance listed in paragraph (1), (2), (2.1), 16    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or 17    (26) of subsection (d) of Section 204, or an analog or 18    derivative thereof, or (ii) 600 or more pills, tablets, 19    caplets, capsules, or objects but less than 1,500 pills, 20    tablets, caplets, capsules, or objects containing in them 21    or having upon them any amount of any substance listed in 22    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), 23    (20.1), (21), (25), or (26) of subsection (d) of Section 24    204, or an analog or derivative thereof;25        (D) not less than 15 years and not more than 60 years 26    with respect to: (i) 900 grams or more of any substance   SB1553- 14 -LRB104 10684 RTM 20763 b1    listed in paragraph (1), (2), (2.1), (2.2), (3), (14.1), 2    (19), (20), (20.1), (21), (25), or (26) of subsection (d) 3    of Section 204, or an analog or derivative thereof, or 4    (ii) 1,500 or more pills, tablets, caplets, capsules, or 5    objects containing in them or having upon them any amount 6    of a substance listed in paragraph (1), (2), (2.1), (2.2), 7    (3), (14.1), (19), (20), (20.1), (21), (25), or (26) of 8    subsection (d) of Section 204, or an analog or derivative 9    thereof;10        (8) 30 grams or more of any substance containing 11    pentazocine or any of the salts, isomers and salts of 12    isomers of pentazocine, or an analog thereof;13        (9) 30 grams or more of any substance containing 14    methaqualone or any of the salts, isomers and salts of 15    isomers of methaqualone, or an analog thereof;16        (10) 30 grams or more of any substance containing 17    phencyclidine or any of the salts, isomers and salts of 18    isomers of phencyclidine (PCP), or an analog thereof;19        (10.5) 30 grams or more of any substance containing 20    ketamine or any of the salts, isomers and salts of isomers 21    of ketamine, or an analog thereof;22        (10.6) 100 grams or more of any substance containing 23    hydrocodone, or any of the salts, isomers and salts of 24    isomers of hydrocodone, or an analog thereof;25        (10.7) (blank);26        (10.8) 100 grams or more of any substance containing   SB1553- 15 -LRB104 10684 RTM 20763 b1    dihydrocodeine, or any of the salts, isomers and salts of 2    isomers of dihydrocodeine, or an analog thereof;3        (10.9) 100 grams or more of any substance containing 4    oxycodone, or any of the salts, isomers and salts of 5    isomers of oxycodone, or an analog thereof;6        (11) 200 grams or more of any substance containing any 7    other controlled substance classified in Schedules I or 8    II, or an analog thereof, which is not otherwise included 9    in this subsection.10    (b) Any person sentenced with respect to violations of 11paragraph (1), (2), (3), (7), or (7.5) of subsection (a) 12involving 100 grams or more of the controlled substance named 13therein, may in addition to the penalties provided therein, be 14fined an amount not more than $500,000 or the full street value 15of the controlled or counterfeit substance or controlled 16substance analog, whichever is greater. The term "street 17value" shall have the meaning ascribed in Section 110-5 of the 18Code of Criminal Procedure of 1963. Any person sentenced with 19respect to any other provision of subsection (a), may in 20addition to the penalties provided therein, be fined an amount 21not to exceed $500,000.22    (b-1) Excluding violations of this Act when the controlled 23substance is fentanyl, any person sentenced to a term of 24imprisonment with respect to violations of Section 401, 401.1, 25405, 405.1, 405.2, or 407, when the substance containing the 26controlled substance contains any amount of fentanyl, 3 years   SB1553- 16 -LRB104 10684 RTM 20763 b1shall be added to the term of imprisonment imposed by the 2court, and the maximum sentence for the offense shall be 3increased by 3 years.4    (c) Any person who violates this Section with regard to 5the following amounts of controlled or counterfeit substances 6or controlled substance analogs, notwithstanding any of the 7provisions of subsections (a), (b), (d), (e), (f), (g) or (h) 8to the contrary, is guilty of a Class 1 felony. The fine for 9violation of this subsection (c) shall not be more than 10$250,000:11        (1) 1 gram or more but less than 15 grams of any 12    substance containing heroin, or an analog thereof;13        (1.5) 1 gram or more but less than 15 grams of any 14    substance containing fentanyl, or an analog thereof;15        (2) 1 gram or more but less than 15 grams of any 16    substance containing cocaine, or an analog thereof;17        (2.5) 1 gram or more but less than 15 grams of any 18    substance containing xylazine, or an analog thereof; 19        (3) 10 grams or more but less than 15 grams of any 20    substance containing morphine, or an analog thereof;21        (4) 50 grams or more but less than 200 grams of any 22    substance containing peyote, or an analog thereof;23        (5) 50 grams or more but less than 200 grams of any 24    substance containing a derivative of barbituric acid or 25    any of the salts of a derivative of barbituric acid, or an 26    analog thereof;  SB1553- 17 -LRB104 10684 RTM 20763 b1        (6) 50 grams or more but less than 200 grams of any 2    substance containing amphetamine or any salt of an optical 3    isomer of amphetamine, or an analog thereof;4        (6.5) (blank);5        (7)(i) 5 grams or more but less than 15 grams of any 6    substance containing lysergic acid diethylamide (LSD), or 7    an analog thereof, or (ii) more than 10 objects or more 8    than 10 segregated parts of an object or objects but less 9    than 15 objects or less than 15 segregated parts of an 10    object containing in them or having upon them any amount 11    of any substance containing lysergic acid diethylamide 12    (LSD), or an analog thereof;13        (7.5)(i) 5 grams or more but less than 15 grams of any 14    substance listed in paragraph (1), (2), (2.1), (2.2), (3), 15    (14.1), (19), (20), (20.1), (21), (25), or (26) of 16    subsection (d) of Section 204, or an analog or derivative 17    thereof, or (ii) more than 10 pills, tablets, caplets, 18    capsules, or objects but less than 15 pills, tablets, 19    caplets, capsules, or objects containing in them or having 20    upon them any amount of any substance listed in paragraph 21    (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), 22    (21), (25), or (26) of subsection (d) of Section 204, or an 23    analog or derivative thereof;24        (8) 10 grams or more but less than 30 grams of any 25    substance containing pentazocine or any of the salts, 26    isomers and salts of isomers of pentazocine, or an analog   SB1553- 18 -LRB104 10684 RTM 20763 b1    thereof;2        (9) 10 grams or more but less than 30 grams of any 3    substance containing methaqualone or any of the salts, 4    isomers and salts of isomers of methaqualone, or an analog 5    thereof;6        (10) 10 grams or more but less than 30 grams of any 7    substance containing phencyclidine or any of the salts, 8    isomers and salts of isomers of phencyclidine (PCP), or an 9    analog thereof;10        (10.5) 10 grams or more but less than 30 grams of any 11    substance containing ketamine or any of the salts, isomers 12    and salts of isomers of ketamine, or an analog thereof;13        (10.6) 50 grams or more but less than 100 grams of any 14    substance containing hydrocodone, or any of the salts, 15    isomers and salts of isomers of hydrocodone, or an analog 16    thereof;17        (10.7) (blank);18        (10.8) 50 grams or more but less than 100 grams of any 19    substance containing dihydrocodeine, or any of the salts, 20    isomers and salts of isomers of dihydrocodeine, or an 21    analog thereof;22        (10.9) 50 grams or more but less than 100 grams of any 23    substance containing oxycodone, or any of the salts, 24    isomers and salts of isomers of oxycodone, or an analog 25    thereof;26        (11) 50 grams or more but less than 200 grams of any   SB1553- 19 -LRB104 10684 RTM 20763 b1    substance containing a substance classified in Schedules I 2    or II, or an analog thereof, which is not otherwise 3    included in this subsection.4    (c-5) (Blank).5    (d) Any person who violates this Section with regard to 6any other amount of a controlled or counterfeit substance 7containing dihydrocodeine or classified in Schedules I or II, 8or an analog thereof, which is (i) a narcotic drug, (ii) 9lysergic acid diethylamide (LSD) or an analog thereof, (iii) 10any substance containing amphetamine or fentanyl or xylazine 11or any salt or optical isomer of amphetamine or fentanyl or 12xylazine, or an analog thereof, or (iv) any substance 13containing N-Benzylpiperazine (BZP) or any salt or optical 14isomer of N-Benzylpiperazine (BZP), or an analog thereof, is 15guilty of a Class 2 felony. The fine for violation of this 16subsection (d) shall not be more than $200,000.17    (d-5) (Blank).18    (e) Any person who violates this Section with regard to 19any other amount of a controlled substance other than 20methamphetamine or counterfeit substance classified in 21Schedule I or II, or an analog thereof, which substance is not 22included under subsection (d) of this Section, is guilty of a 23Class 3 felony. The fine for violation of this subsection (e) 24shall not be more than $150,000.25    (f) Any person who violates this Section with regard to 26any other amount of a controlled or counterfeit substance   SB1553- 20 -LRB104 10684 RTM 20763 b1classified in Schedule III is guilty of a Class 3 felony. The 2fine for violation of this subsection (f) shall not be more 3than $125,000.4    (g) Any person who violates this Section with regard to 5any other amount of a controlled or counterfeit substance 6classified in Schedule IV is guilty of a Class 3 felony. The 7fine for violation of this subsection (g) shall not be more 8than $100,000.9    (h) Any person who violates this Section with regard to 10any other amount of a controlled or counterfeit substance 11classified in Schedule V is guilty of a Class 3 felony. The 12fine for violation of this subsection (h) shall not be more 13than $75,000.14    (i) This Section does not apply to the manufacture, 15possession or distribution of a substance in conformance with 16the provisions of an approved new drug application or an 17exemption for investigational use within the meaning of 18Section 505 of the Federal Food, Drug and Cosmetic Act.19    (j) (Blank).20(Source: P.A. 99-371, eff. 1-1-16; 99-585, eff. 1-1-17; 21100-368, eff. 1-1-18.)


================================================================================

Raw Text:
Full Text of SB1553 ILGA.GOV SB1553 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB1553 Introduced 2/4/2025, by Sen. Patrick J. Joyce SYNOPSIS AS INTRODUCED: 720 ILCS 570/208  from Ch. 56 1/2, par. 1208720 ILCS 570/309.1 new720 ILCS 570/401  from Ch. 56 1/2, par. 1401    Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.LRB104 10684 RTM 20763 b  A BILL FOR SB1553LRB104 10684 RTM 20763 b1    AN ACT concerning criminal law. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Controlled Substances Act is 5amended by changing Sections 208 and 401 and by adding Section 6309.1 as follows: 7    (720 ILCS 570/208)  (from Ch. 56 1/2, par. 1208)8    Sec. 208. (a) The controlled substances listed in this 9Section are included in Schedule III.10    (b) Unless specifically excepted or unless listed in 11another schedule, any material, compound, mixture, or 12preparation which contains any quantity of the following 13substances having a stimulant effect on the central nervous 14system, including its salts, isomers (whether optical 15position, or geometric), and salts of such isomers whenever 16the existence of such salts, isomers, and salts of isomers is 17possible within the specific chemical designation;18        (1) Those compounds, mixtures, or preparations in 19    dosage unit form containing any stimulant substances 20    listed in Schedule II which compounds, mixtures, or 21    preparations were listed on August 25, 1971, as excepted 22    compounds under Title 21, Code of Federal Regulations, 23    Section 308.32, and any other drug of the quantitative   SB1553- 2 -LRB104 10684 RTM 20763 b1    composition shown in that list for those drugs or which is 2    the same except that it contains a lesser quantity of 3    controlled substances;4        (2) Benzphetamine;5        (3) Chlorphentermine;6        (4) Clortermine;7        (5) Phendimetrazine.8    (c) Unless specifically excepted or unless listed in 9another schedule, any material, compound, mixture, or 10preparation which contains any quantity of the following 11substances having a potential for misuse associated with a 12depressant effect on the central nervous system:13        (1) Any compound, mixture, or preparation containing 14    amobarbital, secobarbital, pentobarbital or any salt 15    thereof and one or more other active medicinal ingredients 16    which are not listed in any schedule;17        (2) Any suppository dosage form containing 18    amobarbital, secobarbital, pentobarbital or any salt of 19    any of these drugs and approved by the Federal Food and 20    Drug Administration for marketing only as a suppository;21        (3) Any substance which contains any quantity of a 22    derivative of barbituric acid, or any salt thereof:23        (3.1) Aprobarbital;24        (3.2) Butabarbital (secbutabarbital);25        (3.3) Butalbital;26        (3.4) Butobarbital (butethal);   SB1553- 3 -LRB104 10684 RTM 20763 b1        (4) Chlorhexadol;2        (5) Methyprylon;3        (6) Sulfondiethylmethane;4        (7) Sulfonethylmethane;5        (8) Sulfonmethane;6        (9) Lysergic acid;7        (10) Lysergic acid amide;8        (10.1) Tiletamine or zolazepam or both, or any salt of 9    either of them.10    Some trade or other names for a tiletamine-zolazepam 11    combination product: Telazol. 12    Some trade or other names for Tiletamine: 13    2-(ethylamino)-2-(2-thienyl)-cyclohexanone. 14    Some trade or other names for zolazepam: 15    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo- 16    [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.17        (11) Any material, compound, mixture or preparation 18    containing not more than 12.5 milligrams of pentazocine or 19    any of its salts, per 325 milligrams of aspirin;20        (12) Any material, compound, mixture or preparation 21    containing not more than 12.5 milligrams of pentazocine or 22    any of its salts, per 325 milligrams of acetaminophen;23        (13) Any material, compound, mixture or preparation 24    containing not more than 50 milligrams of pentazocine or 25    any of its salts plus naloxone HCl USP 0.5 milligrams, per 26    dosage unit;  SB1553- 4 -LRB104 10684 RTM 20763 b1        (14) Ketamine;2        (15) Thiopental; . 3        (16) xylazine. 4    (d) Nalorphine.5    (d.5) Buprenorphine. 6    (e) Unless specifically excepted or unless listed in 7another schedule, any material, compound, mixture, or 8preparation containing limited quantities of any of the 9following narcotic drugs, or their salts calculated as the 10free anhydrous base or alkaloid, as set forth below:11        (1) not more than 1.8 grams of codeine per 100 12    milliliters or not more than 90 milligrams per dosage 13    unit, with an equal or greater quantity of an isoquinoline 14    alkaloid of opium;15        (2) not more than 1.8 grams of codeine per 100 16    milliliters or not more than 90 milligrams per dosage 17    unit, with one or more active non-narcotic ingredients in 18    recognized therapeutic amounts;19        (3) (blank);20        (4) (blank);21        (5) not more than 1.8 grams of dihydrocodeine per 100 22    milliliters or not more than 90 milligrams per dosage 23    unit, with one or more active, non-narcotic ingredients in 24    recognized therapeutic amounts;25        (6) not more than 300 milligrams of ethylmorphine per 26    100 milliliters or not more than 15 milligrams per dosage   SB1553- 5 -LRB104 10684 RTM 20763 b1    unit, with one or more active, non-narcotic ingredients in 2    recognized therapeutic amounts;3        (7) not more than 500 milligrams of opium per 100 4    milliliters or per 100 grams, or not more than 25 5    milligrams per dosage unit, with one or more active, 6    non-narcotic ingredients in recognized therapeutic 7    amounts;8        (8) not more than 50 milligrams of morphine per 100 9    milliliters or per 100 grams with one or more active, 10    non-narcotic ingredients in recognized therapeutic 11    amounts.12    (f) Anabolic steroids, except the following anabolic 13steroids that are exempt:14        (1) Androgyn L.A.;15        (2) Andro-Estro 90-4;16        (3) depANDROGYN;17        (4) DEPO-T.E.;18        (5) depTESTROGEN;19        (6) Duomone;20        (7) DURATESTRIN;21        (8) DUO-SPAN II;22        (9) Estratest;23        (10) Estratest H.S.;24        (11) PAN ESTRA TEST;25        (12) Premarin with Methyltestosterone;26        (13) TEST-ESTRO Cypionates;  SB1553- 6 -LRB104 10684 RTM 20763 b1        (14) Testosterone Cyp 50 Estradiol Cyp 2;2        (15) Testosterone Cypionate-Estradiol Cypionate 3    injection; and4        (16) Testosterone Enanthate-Estradiol Valerate 5    injection.6    (g) Hallucinogenic substances.7        (1) Dronabinol (synthetic) in sesame oil and 8    encapsulated in a soft gelatin capsule in a U.S. Food and 9    Drug Administration approved product. Some other names for 10    dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro- 11    6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or 12    (-)-delta-9-(trans)-tetrahydrocannabinol.13        (2) (Reserved).14    (h) The Department may except by rule any compound, 15mixture, or preparation containing any stimulant or depressant 16substance listed in subsection (b) from the application of all 17or any part of this Act if the compound, mixture, or 18preparation contains one or more active medicinal ingredients 19not having a stimulant or depressant effect on the central 20nervous system, and if the admixtures are included therein in 21combinations, quantity, proportion, or concentration that 22vitiate the potential for misuse of the substances which have 23a stimulant or depressant effect on the central nervous 24system.25(Source: P.A. 103-881, eff. 1-1-25.)   SB1553- 7 -LRB104 10684 RTM 20763 b1    (720 ILCS 570/309.1 new)2    Sec. 309.1. Veterinarian; xylazine. Notwithstanding the 3scheduling of xylazine as a Schedule III controlled substance, 4the prohibition on delivery or possession with intent to 5deliver xylazine does not apply to licensed veterinarians who 6lawfully prescribe, dispense, administer, acquire, or use any 7controlled substance, including xylazine, while acting in the 8course of their professional practice, in good faith, and in 9accordance with generally accepted medical standards. 10    (720 ILCS 570/401)  (from Ch. 56 1/2, par. 1401)11    Sec. 401. Manufacture or delivery, or possession with 12intent to manufacture or deliver, a controlled substance, a 13counterfeit substance, or controlled substance analog. Except 14as authorized by this Act, it is unlawful for any person 15knowingly to manufacture or deliver, or possess with intent to 16manufacture or deliver, a controlled substance other than 17methamphetamine and other than bath salts as defined in the 18Bath Salts Prohibition Act sold or offered for sale in a retail 19mercantile establishment as defined in Section 16-0.1 of the 20Criminal Code of 2012, a counterfeit substance, or a 21controlled substance analog. A violation of this Act with 22respect to each of the controlled substances listed herein 23constitutes a single and separate violation of this Act. For 24purposes of this Section, "controlled substance analog" or 25"analog" means a substance, other than a controlled substance,   SB1553- 8 -LRB104 10684 RTM 20763 b1which is not approved by the United States Food and Drug 2Administration or, if approved, is not dispensed or possessed 3in accordance with State or federal law, and that has a 4chemical structure substantially similar to that of a 5controlled substance in Schedule I or II, or that was 6specifically designed to produce an effect substantially 7similar to that of a controlled substance in Schedule I or II. 8Examples of chemical classes in which controlled substance 9analogs are found include, but are not limited to, the 10following: phenethylamines, N-substituted piperidines, 11morphinans, ecgonines, quinazolinones, substituted indoles, 12and arylcycloalkylamines. For purposes of this Act, a 13controlled substance analog shall be treated in the same 14manner as the controlled substance to which it is 15substantially similar.16    (a) Any person who violates this Section with respect to 17the following amounts of controlled or counterfeit substances 18or controlled substance analogs, notwithstanding any of the 19provisions of subsections (c), (d), (e), (f), (g) or (h) to the 20contrary, is guilty of a Class X felony and shall be sentenced 21to a term of imprisonment as provided in this subsection (a) 22and fined as provided in subsection (b):23        (1)(A) not less than 6 years and not more than 30 years 24    with respect to 15 grams or more but less than 100 grams of 25    a substance containing heroin, or an analog thereof;26        (B) not less than 9 years and not more than 40 years   SB1553- 9 -LRB104 10684 RTM 20763 b1    with respect to 100 grams or more but less than 400 grams 2    of a substance containing heroin, or an analog thereof;3        (C) not less than 12 years and not more than 50 years 4    with respect to 400 grams or more but less than 900 grams 5    of a substance containing heroin, or an analog thereof;6        (D) not less than 15 years and not more than 60 years 7    with respect to 900 grams or more of any substance 8    containing heroin, or an analog thereof;9        (1.5)(A) not less than 6 years and not more than 30 10    years with respect to 15 grams or more but less than 100 11    grams of a substance containing fentanyl or xylazine, or 12    an analog thereof;13        (B) not less than 9 years and not more than 40 years 14    with respect to 100 grams or more but less than 400 grams 15    of a substance containing fentanyl or xylazine, or an 16    analog thereof;17        (C) not less than 12 years and not more than 50 years 18    with respect to 400 grams or more but less than 900 grams 19    of a substance containing fentanyl or xylazine, or an 20    analog thereof;21        (D) not less than 15 years and not more than 60 years 22    with respect to 900 grams or more of a substance 23    containing fentanyl or xylazine, or an analog thereof;24        (2)(A) not less than 6 years and not more than 30 years 25    with respect to 15 grams or more but less than 100 grams of 26    a substance containing cocaine, or an analog thereof;  SB1553- 10 -LRB104 10684 RTM 20763 b1        (B) not less than 9 years and not more than 40 years 2    with respect to 100 grams or more but less than 400 grams 3    of a substance containing cocaine, or an analog thereof;4        (C) not less than 12 years and not more than 50 years 5    with respect to 400 grams or more but less than 900 grams 6    of a substance containing cocaine, or an analog thereof;7        (D) not less than 15 years and not more than 60 years 8    with respect to 900 grams or more of any substance 9    containing cocaine, or an analog thereof;10        (3)(A) not less than 6 years and not more than 30 years 11    with respect to 15 grams or more but less than 100 grams of 12    a substance containing morphine, or an analog thereof;13        (B) not less than 9 years and not more than 40 years 14    with respect to 100 grams or more but less than 400 grams 15    of a substance containing morphine, or an analog thereof;16        (C) not less than 12 years and not more than 50 years 17    with respect to 400 grams or more but less than 900 grams 18    of a substance containing morphine, or an analog thereof;19        (D) not less than 15 years and not more than 60 years 20    with respect to 900 grams or more of a substance 21    containing morphine, or an analog thereof;22        (4) 200 grams or more of any substance containing 23    peyote, or an analog thereof;24        (5) 200 grams or more of any substance containing a 25    derivative of barbituric acid or any of the salts of a 26    derivative of barbituric acid, or an analog thereof;  SB1553- 11 -LRB104 10684 RTM 20763 b1        (6) 200 grams or more of any substance containing 2    amphetamine or any salt of an optical isomer of 3    amphetamine, or an analog thereof;4        (6.5) (blank);5        (6.6) (blank);6        (7)(A) not less than 6 years and not more than 30 years 7    with respect to: (i) 15 grams or more but less than 100 8    grams of a substance containing lysergic acid diethylamide 9    (LSD), or an analog thereof, or (ii) 15 or more objects or 10    15 or more segregated parts of an object or objects but 11    less than 200 objects or 200 segregated parts of an object 12    or objects containing in them or having upon them any 13    amounts of any substance containing lysergic acid 14    diethylamide (LSD), or an analog thereof;15        (B) not less than 9 years and not more than 40 years 16    with respect to: (i) 100 grams or more but less than 400 17    grams of a substance containing lysergic acid diethylamide 18    (LSD), or an analog thereof, or (ii) 200 or more objects or 19    200 or more segregated parts of an object or objects but 20    less than 600 objects or less than 600 segregated parts of 21    an object or objects containing in them or having upon 22    them any amount of any substance containing lysergic acid 23    diethylamide (LSD), or an analog thereof;24        (C) not less than 12 years and not more than 50 years 25    with respect to: (i) 400 grams or more but less than 900 26    grams of a substance containing lysergic acid diethylamide   SB1553- 12 -LRB104 10684 RTM 20763 b1    (LSD), or an analog thereof, or (ii) 600 or more objects or 2    600 or more segregated parts of an object or objects but 3    less than 1500 objects or 1500 segregated parts of an 4    object or objects containing in them or having upon them 5    any amount of any substance containing lysergic acid 6    diethylamide (LSD), or an analog thereof;7        (D) not less than 15 years and not more than 60 years 8    with respect to: (i) 900 grams or more of any substance 9    containing lysergic acid diethylamide (LSD), or an analog 10    thereof, or (ii) 1500 or more objects or 1500 or more 11    segregated parts of an object or objects containing in 12    them or having upon them any amount of a substance 13    containing lysergic acid diethylamide (LSD), or an analog 14    thereof;15    (7.5)(A) not less than 6 years and not more than 30 years 16    with respect to: (i) 15 grams or more but less than 100 17    grams of a substance listed in paragraph (1), (2), (2.1), 18    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or 19    (26) of subsection (d) of Section 204, or an analog or 20    derivative thereof, or (ii) 15 or more pills, tablets, 21    caplets, capsules, or objects but less than 200 pills, 22    tablets, caplets, capsules, or objects containing in them 23    or having upon them any amounts of any substance listed in 24    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), 25    (20.1), (21), (25), or (26) of subsection (d) of Section 26    204, or an analog or derivative thereof;  SB1553- 13 -LRB104 10684 RTM 20763 b1        (B) not less than 9 years and not more than 40 years 2    with respect to: (i) 100 grams or more but less than 400 3    grams of a substance listed in paragraph (1), (2), (2.1), 4    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or 5    (26) of subsection (d) of Section 204, or an analog or 6    derivative thereof, or (ii) 200 or more pills, tablets, 7    caplets, capsules, or objects but less than 600 pills, 8    tablets, caplets, capsules, or objects containing in them 9    or having upon them any amount of any substance listed in 10    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), 11    (20.1), (21), (25), or (26) of subsection (d) of Section 12    204, or an analog or derivative thereof;13        (C) not less than 12 years and not more than 50 years 14    with respect to: (i) 400 grams or more but less than 900 15    grams of a substance listed in paragraph (1), (2), (2.1), 16    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or 17    (26) of subsection (d) of Section 204, or an analog or 18    derivative thereof, or (ii) 600 or more pills, tablets, 19    caplets, capsules, or objects but less than 1,500 pills, 20    tablets, caplets, capsules, or objects containing in them 21    or having upon them any amount of any substance listed in 22    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), 23    (20.1), (21), (25), or (26) of subsection (d) of Section 24    204, or an analog or derivative thereof;25        (D) not less than 15 years and not more than 60 years 26    with respect to: (i) 900 grams or more of any substance   SB1553- 14 -LRB104 10684 RTM 20763 b1    listed in paragraph (1), (2), (2.1), (2.2), (3), (14.1), 2    (19), (20), (20.1), (21), (25), or (26) of subsection (d) 3    of Section 204, or an analog or derivative thereof, or 4    (ii) 1,500 or more pills, tablets, caplets, capsules, or 5    objects containing in them or having upon them any amount 6    of a substance listed in paragraph (1), (2), (2.1), (2.2), 7    (3), (14.1), (19), (20), (20.1), (21), (25), or (26) of 8    subsection (d) of Section 204, or an analog or derivative 9    thereof;10        (8) 30 grams or more of any substance containing 11    pentazocine or any of the salts, isomers and salts of 12    isomers of pentazocine, or an analog thereof;13        (9) 30 grams or more of any substance containing 14    methaqualone or any of the salts, isomers and salts of 15    isomers of methaqualone, or an analog thereof;16        (10) 30 grams or more of any substance containing 17    phencyclidine or any of the salts, isomers and salts of 18    isomers of phencyclidine (PCP), or an analog thereof;19        (10.5) 30 grams or more of any substance containing 20    ketamine or any of the salts, isomers and salts of isomers 21    of ketamine, or an analog thereof;22        (10.6) 100 grams or more of any substance containing 23    hydrocodone, or any of the salts, isomers and salts of 24    isomers of hydrocodone, or an analog thereof;25        (10.7) (blank);26        (10.8) 100 grams or more of any substance containing   SB1553- 15 -LRB104 10684 RTM 20763 b1    dihydrocodeine, or any of the salts, isomers and salts of 2    isomers of dihydrocodeine, or an analog thereof;3        (10.9) 100 grams or more of any substance containing 4    oxycodone, or any of the salts, isomers and salts of 5    isomers of oxycodone, or an analog thereof;6        (11) 200 grams or more of any substance containing any 7    other controlled substance classified in Schedules I or 8    II, or an analog thereof, which is not otherwise included 9    in this subsection.10    (b) Any person sentenced with respect to violations of 11paragraph (1), (2), (3), (7), or (7.5) of subsection (a) 12involving 100 grams or more of the controlled substance named 13therein, may in addition to the penalties provided therein, be 14fined an amount not more than $500,000 or the full street value 15of the controlled or counterfeit substance or controlled 16substance analog, whichever is greater. The term "street 17value" shall have the meaning ascribed in Section 110-5 of the 18Code of Criminal Procedure of 1963. Any person sentenced with 19respect to any other provision of subsection (a), may in 20addition to the penalties provided therein, be fined an amount 21not to exceed $500,000.22    (b-1) Excluding violations of this Act when the controlled 23substance is fentanyl, any person sentenced to a term of 24imprisonment with respect to violations of Section 401, 401.1, 25405, 405.1, 405.2, or 407, when the substance containing the 26controlled substance contains any amount of fentanyl, 3 years   SB1553- 16 -LRB104 10684 RTM 20763 b1shall be added to the term of imprisonment imposed by the 2court, and the maximum sentence for the offense shall be 3increased by 3 years.4    (c) Any person who violates this Section with regard to 5the following amounts of controlled or counterfeit substances 6or controlled substance analogs, notwithstanding any of the 7provisions of subsections (a), (b), (d), (e), (f), (g) or (h) 8to the contrary, is guilty of a Class 1 felony. The fine for 9violation of this subsection (c) shall not be more than 10$250,000:11        (1) 1 gram or more but less than 15 grams of any 12    substance containing heroin, or an analog thereof;13        (1.5) 1 gram or more but less than 15 grams of any 14    substance containing fentanyl, or an analog thereof;15        (2) 1 gram or more but less than 15 grams of any 16    substance containing cocaine, or an analog thereof;17        (2.5) 1 gram or more but less than 15 grams of any 18    substance containing xylazine, or an analog thereof; 19        (3) 10 grams or more but less than 15 grams of any 20    substance containing morphine, or an analog thereof;21        (4) 50 grams or more but less than 200 grams of any 22    substance containing peyote, or an analog thereof;23        (5) 50 grams or more but less than 200 grams of any 24    substance containing a derivative of barbituric acid or 25    any of the salts of a derivative of barbituric acid, or an 26    analog thereof;  SB1553- 17 -LRB104 10684 RTM 20763 b1        (6) 50 grams or more but less than 200 grams of any 2    substance containing amphetamine or any salt of an optical 3    isomer of amphetamine, or an analog thereof;4        (6.5) (blank);5        (7)(i) 5 grams or more but less than 15 grams of any 6    substance containing lysergic acid diethylamide (LSD), or 7    an analog thereof, or (ii) more than 10 objects or more 8    than 10 segregated parts of an object or objects but less 9    than 15 objects or less than 15 segregated parts of an 10    object containing in them or having upon them any amount 11    of any substance containing lysergic acid diethylamide 12    (LSD), or an analog thereof;13        (7.5)(i) 5 grams or more but less than 15 grams of any 14    substance listed in paragraph (1), (2), (2.1), (2.2), (3), 15    (14.1), (19), (20), (20.1), (21), (25), or (26) of 16    subsection (d) of Section 204, or an analog or derivative 17    thereof, or (ii) more than 10 pills, tablets, caplets, 18    capsules, or objects but less than 15 pills, tablets, 19    caplets, capsules, or objects containing in them or having 20    upon them any amount of any substance listed in paragraph 21    (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), 22    (21), (25), or (26) of subsection (d) of Section 204, or an 23    analog or derivative thereof;24        (8) 10 grams or more but less than 30 grams of any 25    substance containing pentazocine or any of the salts, 26    isomers and salts of isomers of pentazocine, or an analog   SB1553- 18 -LRB104 10684 RTM 20763 b1    thereof;2        (9) 10 grams or more but less than 30 grams of any 3    substance containing methaqualone or any of the salts, 4    isomers and salts of isomers of methaqualone, or an analog 5    thereof;6        (10) 10 grams or more but less than 30 grams of any 7    substance containing phencyclidine or any of the salts, 8    isomers and salts of isomers of phencyclidine (PCP), or an 9    analog thereof;10        (10.5) 10 grams or more but less than 30 grams of any 11    substance containing ketamine or any of the salts, isomers 12    and salts of isomers of ketamine, or an analog thereof;13        (10.6) 50 grams or more but less than 100 grams of any 14    substance containing hydrocodone, or any of the salts, 15    isomers and salts of isomers of hydrocodone, or an analog 16    thereof;17        (10.7) (blank);18        (10.8) 50 grams or more but less than 100 grams of any 19    substance containing dihydrocodeine, or any of the salts, 20    isomers and salts of isomers of dihydrocodeine, or an 21    analog thereof;22        (10.9) 50 grams or more but less than 100 grams of any 23    substance containing oxycodone, or any of the salts, 24    isomers and salts of isomers of oxycodone, or an analog 25    thereof;26        (11) 50 grams or more but less than 200 grams of any   SB1553- 19 -LRB104 10684 RTM 20763 b1    substance containing a substance classified in Schedules I 2    or II, or an analog thereof, which is not otherwise 3    included in this subsection.4    (c-5) (Blank).5    (d) Any person who violates this Section with regard to 6any other amount of a controlled or counterfeit substance 7containing dihydrocodeine or classified in Schedules I or II, 8or an analog thereof, which is (i) a narcotic drug, (ii) 9lysergic acid diethylamide (LSD) or an analog thereof, (iii) 10any substance containing amphetamine or fentanyl or xylazine 11or any salt or optical isomer of amphetamine or fentanyl or 12xylazine, or an analog thereof, or (iv) any substance 13containing N-Benzylpiperazine (BZP) or any salt or optical 14isomer of N-Benzylpiperazine (BZP), or an analog thereof, is 15guilty of a Class 2 felony. The fine for violation of this 16subsection (d) shall not be more than $200,000.17    (d-5) (Blank).18    (e) Any person who violates this Section with regard to 19any other amount of a controlled substance other than 20methamphetamine or counterfeit substance classified in 21Schedule I or II, or an analog thereof, which substance is not 22included under subsection (d) of this Section, is guilty of a 23Class 3 felony. The fine for violation of this subsection (e) 24shall not be more than $150,000.25    (f) Any person who violates this Section with regard to 26any other amount of a controlled or counterfeit substance   SB1553- 20 -LRB104 10684 RTM 20763 b1classified in Schedule III is guilty of a Class 3 felony. The 2fine for violation of this subsection (f) shall not be more 3than $125,000.4    (g) Any person who violates this Section with regard to 5any other amount of a controlled or counterfeit substance 6classified in Schedule IV is guilty of a Class 3 felony. The 7fine for violation of this subsection (g) shall not be more 8than $100,000.9    (h) Any person who violates this Section with regard to 10any other amount of a controlled or counterfeit substance 11classified in Schedule V is guilty of a Class 3 felony. The 12fine for violation of this subsection (h) shall not be more 13than $75,000.14    (i) This Section does not apply to the manufacture, 15possession or distribution of a substance in conformance with 16the provisions of an approved new drug application or an 17exemption for investigational use within the meaning of 18Section 505 of the Federal Food, Drug and Cosmetic Act.19    (j) (Blank).20(Source: P.A. 99-371, eff. 1-1-16; 99-585, eff. 1-1-17; 21100-368, eff. 1-1-18.)